Roivant Announces Redemption Fair Market Value in Connection with Redemption of its Outstanding Warrants
BASEL, Switzerland and LONDON and NEW YORK, Aug. 17, 2023 (GLOBE NEWSWIRE) — Roivant (Nasdaq:…
News
Myriad Genetics to Host Investor Day on September 19, 2023
SALT LAKE CITY, Aug. 17, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
FORT WORTH, Texas, Aug. 17, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (the…
Major Upgrades to the ISA100 Wireless(TM) Product Capabilities
ISA100 Wireless now supports Bluetooth Low Energy and OPC-UA Durham, North Carolina–(Newsfile Corp. – August…
Rigel Technologies Announces Corporate Update
Toronto, Ontario–(Newsfile Corp. – August 17, 2023) – Rigel Technologies Inc. (the “Company“) wishes to…
TrueNorth Welcomes Brandy Young to Advisory Board
NEW YORK–(BUSINESS WIRE)–TrueNorth, a leading global financial technology services company, today announced the pivotal addition…
Fastwyre Brings Fast Fiber-Optic Network to Nevada, Mo.
Broadband service provider offers affordable, reliable, high-speed internet Fastwyre Broadband Launches Fast Fiber-Optic Network in…
ZeroFox Named Digital Risk Protection Leader by Quadrant Knowledge Solutions in 2023 SPARK Matrix™
WASHINGTON, Aug. 17, 2023 (GLOBE NEWSWIRE) — ZeroFox, (Nasdaq: ZFOX), an enterprise software-as-a-service leader in…
Cross River Teams Up with Atlanta-Based Organizations, The Empty Stocking Fund and Caden Teaches Finances, to Bring School Supplies and Financial Literacy to Local Students and Educators
Organizations provide essential supplies for teachers and foster financial empowerment for youth, as financial institution…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Applied Digital Corporation (APLD) Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Leeward Renewable Energy Completes Construction and Commences Commercial Operations at Oak Trail Solar in North Carolina
100-MW renewable energy facility will deliver significant economic benefits to the local community over the…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Waldencast plc (WALD, WALDW) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
ABVC Executes Cooperation Agreement for Strategic Investments
FREMONT, CA, Aug. 17, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) (“Company”),…
Pattern Ag amplifies analytics tool to predict the presence of foliar diseases in corn and soybeans
Complete Bio Panel now includes new field analysis for corn with Tar Spot, Gray Leaf…
KWESST Announces Grant of Stock Options
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY,…
Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics
NEW YORK, Aug 17, 2023 – (ACN Newswire) – PCG Digital — Driving towards its…
Anura Claims Position on Inc. 5000 List of Fastest-Growing Private Companies for 2023
MIDDLETOWN, Delaware, August 15, 2023 – Anura Solutions, LLC announced today that they have been…
Odronextamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
TARRYTOWN, N.Y., Aug. 17, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced…
Odronextamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
TARRYTOWN, N.Y., Aug. 17, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced…
Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors
CARLSBAD, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage…